Author

Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

59 | EXPLORATORY THERAPEUTIC APPROACH IN DERCUM’S DISEASE: IMMUNOMODULATORS AND GLP-1 RECEPTOR AGONISTS

Dercum’s disease (DD) is a rare chronic disorder characterized by painful subcutaneous lipomas, predominantly affecting overweight or obese middle-aged women. According to lesion distribution and extent, Hansson et al. classified DD into four types: generalized diffuse (I), generalized nodular (II), localized nodular (...

Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica · Dermatology Reports · 0 citations

Open access Sep 2026

40 | BEYOND THE USUAL CAT: TRICHOPHYTON BENHAMIAE KERION CELSI IN A CHILD WITH CHINCHILLA-ASSOCIATED HOUSEHOLD OUTBREAK

Introduction. Trichophyton benhamiae is an emerging zoophilic dermatophyte increasingly reported as a cause of inflammatory tinea in children, including kerion celsi. Due to its variable epidemiological sources and often misleading exposure history, accurate identification of the infection source may be challenging and...

Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica · Dermatology Reports · 0 citations

Open access Sep 2026

25 | EARLY AND MAINTAINED TREAT-TO-TARGET RESPONSE WITH IXEKIZUMAB UP TO 5 YEARS IN MODERATE-TO-SEVERE PSORIASIS: A POST-HOC ANALYSIS OF UNCOVER-3

Background. The National Psoriasis Foundation recommends evaluating treatment response at Week12, with a target body surface area (BSA) ≤1% affected and an acceptable response of BSA≤3%1. European consensuses emphasize a shift from relative outcomes such as Psoriasis Area and Severity Index (PASI) scores of 90/100 towa...

Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica · Dermatology Reports · 0 citations